The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin
Open accessAbstract
Cholangiolocellular carcinoma (CLC), a subtype of cholangiocellular carcinoma (CC), is thought to originate from the ductules/canals of Hering, where hepatic progenitor cells (HPCs) are located. We investigated the clinicopathological features of 30 CLCs and their relationship to HPCs. We evaluated the expression of hepatocytic markers (hepatocyte paraffin-1, canalicular polyclonal carcinoembryonic antigen, and CD10), biliary/HPC markers (keratin [K]7, K19, and neural cell adhesion molecule), the adenosine triphosphate binding cassette transporters: multidrug resistance protein 1, multidrug resistance-associated protein (MRP)1, MRP3, and breast cancer resistance protein, using immunohistochemistry and electron microscopy. In addition, gene expression profiling of CLC was performed and compared with the profile of hepatocellular carcinoma (HCC) with or without HPC features (K19 expression). In surrounding nontumoral tissue, K7-positive and K19-positive HPCs/ductular reaction were observed. More than 90% of the tumor was composed of CLC areas that showed small monotonous and/or anastomosing glands, strongly positive for K7 and K19. Especially at the tumor boundary, all cases showed a HCC-like trabecular area characterized by canalicular CD10/polyclonal carcinoembryonic antigen expression, and submembranous K7 expression, similar to intermediate hepatocytes. K7-positive/K19-positive HPCs were also seen. Out of 30 cases, 19 showed papillary and/or clear glandular formation with mucin production, representing CC areas. These three different areas showed transitional zones with each other. We observed an increased expression of MRP1, MRP3, and breast cancer resistance protein in the tumor. Electron microscopy findings in HCC-like trabecular areas confirmed the presence of HPCs and intermediate hepatocytes. HPC markers, K7, K19, prominin-1, receptor for stem cell factor c-kit, octamer-4 transcription factor, and leukemia inhibitory factor were upregulated ( P < 0.05), while albumin was downregulated in CLC ( P = 0.007) toward K19-negative HCCs. Comparison of CLC with K19-positive HCCs indicated a high homology. Conclusion: All these findings highly suggest a progenitor cell origin of CLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Self-citationA novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Lee, J.-S., Heo, J., Libbrecht, L., Chu, I.-S., Kaposi-Novak, P., Calvisi, D. F., Mikaelyan, A., Roberts, L. R., Demetris, A. J., Sun, Z., et al. (2006) · Nature Medicine · doi:10.1038/nm1377 · Cited by 953
Self-citationRoskams, T. A., Theise, N. D., Balabaud, C., Bhagat, G., Bhathal, P. S., Bioulac-Sage, P., Brunt, E. M., Crawford, J. M., Crosby, H. A., Desmet, V., et al. (2004) · Hepatology · doi:10.1002/hep.20130 · Cited by 735
Self-citationThe canals of hering and hepatic stem cells in humans
Theise, N. D., Saxena, R., Portmann, B. C., Thung, S. N., Yee, H., Chiriboga, L., Kumar, A., & Crawford, J. M. (1999) · Hepatology · doi:10.1002/hep.510300614 · Cited by 702
Tai, M.-H. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh321 · Cited by 591
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity
Yin, S., Li, J., Hu, C., Chen, X., Yao, M., Yan, M., Jiang, G., Ge, C., Xie, H., Wan, D., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22476 · Cited by 555
Durnez, A., Verslype, C., Nevens, F., Fevery, J., Aerts, R., Pirenne, J., Lesaffre, E., Libbrecht, L., Desmet, V, & Roskams, T. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02468.x · Cited by 426
Self-citationLiver stem cells and their implication in hepatocellular and cholangiocarcinoma
Roskams, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209558 · Cited by 422
Self-citationProgenitor Cells in Diseased Human Liver
(2003) · Seminars in Liver Disease · doi:10.1055/s-2004-815564 · Cited by 336
Roskams, T., De Vos, R., Van Eyken, P., Myazaki, H., Van Damme, B., & Desmet, V. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80065-2 · Cited by 287
Self-citationCytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence
Uenishi, T., Kubo, S., Yamamoto, T., Shuto, T., Ogawa, M., Tanaka, H., Tanaka, S., Kaneda, K., & Hirohashi, K. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01366.x · Cited by 269
Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium
Crosby, H. A., Kelly, D. A., & Strain, A. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.21175 · Cited by 238
Ros, J. E., Libbrecht, L., Geuken, M., Jansen, P. L., & Roskams, T. A. (2003) · The Journal of Pathology · doi:10.1002/path.1379 · Cited by 198
Self-citationLibbrecht, L., Desmet, V., Damme, B. V., & Roskams, T. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80162-2 · Cited by 165
Self-citationHepatic Progenitor Cells in Hepatocellular Adenomas
Libbrecht, L. J., Vos, R. D., Cassiman, D. M., Desmet, V. J., Aerts, R., & Roskams, T. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200111000-00006 · Cited by 126
Self-citationFrom Adult Stem Cells to Cancer Stem Cells
Trosko, J. E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.018 · Cited by 122
Vos, R. D., & Desmet, V. J. (1992) · PubMed Central · Cited by 121
Self-citationProgenitor cell involvement in cirrhotic human liver diseases: from controversy to consensus
Roskams, T. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00333-7 · Cited by 94
Self-citationBorght, S. V., Libbrecht, L. J., Katoonizadeh, A., van Pelt, J. F., Cassiman, D. M., Nevens, F., Lommel, A. V., Petersen, B. E., Fevery, J., Jansen, P. L. M., et al. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6912.2006 · Cited by 69
Self-citationExpression of oncostatin M and its receptors in normal and cirrhotic human liver
Znoyko, I. Y., Sohara, N., Spicer, S. S., Trojanowska, M., & Reuben, A. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.04.020 · Cited by 51
Nomoto, K., Tsuneyama, K., Cheng, C., Takahashi, H., Hori, R., Murai, Y., & Takano, Y. (2005) · Pathology - Research and Practice · doi:10.1016/j.prp.2005.10.011 · Cited by 49
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Banales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., et al. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.51 · Cited by 1,376
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Ilyas, S. I., & Gores, G. J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.013 · Cited by 1,307
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Sia, D., Villanueva, A., Friedman, S. L., & Llovet, J. M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.048 · Cited by 1,153
The immunological and metabolic landscape in primary and metastatic liver cancer
Li, X., Ramadori, P., Pfister, D., Seehawer, M., Zender, L., & Heikenwalder, M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00383-9 · Cited by 616
Metadata
- Authors
- Komuta, M., Spee, B., Borght, S. V., De Vos, R., Verslype, C., Aerts, R., Yano, H., Suzuki, T., Matsuda, M., Fujii, H., Desmet, V. J., Kojiro, M., & Roskams, T.
- Venue
- Hepatology
- Published
- 2008-05
- Volume
- 47
- Issue
- 5
- Pages
- 1544-1556
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2016411184
- Cited by
- 363
- References
- 21
- FWCI
- 20.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.